🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Genetic Study of Immunodeficiency: Search for New Genetic Causes for Primary Immunodeficiencies

Recruitingn/aAges any - anyAllUniversity Children's Hospital, Zurich
NCT02735824 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Individuals with suspected primary immunodeficiency will be studied and the results compared with healthy controls. Primary immunodeficiency may manifest as recurrent, severe or unusual infections as well as signs and symptoms of immune dysregulation such as autoimmunity or lymphoproliferation.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Patients: Pediatric patients (in/outpatient or referred) with suspected or confirmed Inborn Errors of Immunity. * Relatives: Healthy or affected biological relatives of enrolled patients. * Controls: Healthy volunteers with no history of chronic immunological, inflammatory, or infectious disease. * Consent: Ability to provide signed informed consent (or guardian consent).
💊

What it tests

  • Skin Biopsy
  • Mouth Swab or Saliva Collection
  • Blood Sampling
📍

Where

1 site
Division of Immunology
Zurich, Switzerland
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy